Purchase Order HHSN275201700682P

This federal contract award was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to GVK Biosciences Private Limited, a for-profit organization, with a ceiling value of $20,020.00. The contract was awarded on June 29, 2015, with a performance period ending on December 31, 2015. The contract type is a Firm Fixed Price Purchase Order, and it does not have a set-aside designation. The place of performance is India. This award appears to be...

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a firm fixed price purchase order to JAI Research Foundation on September 22, 2018, with a ceiling value of $17,754.24. Place of performance is India. The order ultimate completion date was March 22, 2019.</p>

The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to JAI Research Foundation on July 1, 2026, for preclinical toxicity testing services valued at $58,200.00, with completion by June 30, 2027. Work is performed in India. The order covers toxicity testing for novel drugs to support drug discovery within the Laboratory of Bioorganic Chemistry, focusing on solubility and bioavailability assessments. The procurement emphasizes protocol consistency with...

This is a $20,960 fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to the JAI Research Foundation, a non-profit organization. The contract is for solubility, stability, and toxicology studies to advance novel drug candidates developed by the NIDDK into clinical trials. This contract was awarded on September 25, 2020 and has a completion date of September 24, 2021. The contract stems from a small...

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Cosmo Bio USA Inc. for $32,936.00 on August 22, 2019. Work is performed in Carlsbad, California. The order is priced on a firm fixed price basis with an ultimate completion date of February 24, 2020. The originating pre-solicitation opportunity was posted July 28, 2019 with an August 6, 2019 due date.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation for $24,545.41 on August 10, 2016. The order procures various laboratory equipment on a firm fixed price basis. Place of performance is Carlsbad, California. The order is scheduled for completion by September 30, 2016.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation on September 15, 2016, for various laboratory supplies with a firm fixed price of $6,684.06. Performance will occur in Grand Island, New York. The order carries an ultimate completion date of September 19, 2017.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to LGC Genomics LLC for $8,890.00 on May 28, 2014, with completion due June 2, 2014. The order is firm fixed price with no set-aside designation. Work is performed in Beverly, Massachusetts. The source does not specify the goods or services being procured.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to LGC Genomics LLC for $8,361.40 on April 1, 2015. Work is performed in Bethesda, Maryland. The order was issued with no set-aside designation and carries a firm fixed-price structure. Ultimate completion is scheduled for April 10, 2015.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation (operating as Thermo Fisher Scientific) on September 15, 2017, valued at $58,800.00. This modification changed the vendor due to a novation agreement. Performance occurs in Carlsbad, California, with an ultimate completion date of February 28, 2018. The order is firm fixed price with no set-aside applied.</p>